# Alternative Intelligence Investigation: Respiratory Illness Outbreak Monitoring (Baseline: 2025-12-06)

## Executive Summary

This investigative analytical report consolidates open-source intelligence (OSINT) from social media, mainstream and alternative media, and official public health channels to assess the respiratory illness landscape as of the 2025-12-06 baseline. Across jurisdictions, the prevailing signal is an influenza A(H3N2)-dominant season, with early and steep rises in several countries and subnational regions. Within the United States, national dashboards still register low levels of acute respiratory illness as of early December, yet on-the-ground signals from emergency departments (EDs) and clinicians point to mounting pressure, particularly in Adelaide and Northern Ontario, where system stressors are most visible[^10][^6][^8][^9].

The strongest cross-source convergence concerns three themes. First, H3N2—specifically a drifted variant referred to as “subclade K”—is dominant in the United Kingdom and Japan and is present in the United States, with news and scientific sources flagging a likely vaccine mismatch and uncertainty around vaccine effectiveness (VE). Second, hospital capacity strain signals are geographically clustered and severe in specific EDs, notably Adelaide, where “hidden ramping” and admitted inpatients exceeding ED bed capacity were reported. Third, surveillance blackouts and data disruptions—in particular the pause of national respiratory dashboards in the United States since September—have materially weakened situational awareness just as the season intensifies[^4][^1][^2][^6][^8][^9][^10].

Against this backdrop, citizen and clinician narratives exhibit high alignment with official summaries on seasonality and dominant respiratory pathogens. However, several contradictions are notable. In online conversations, some commentators allege that SARS-CoV-2 cases are being misclassified as influenza or “viral” illness; others invoke long COVID and immunity debt hypotheses; and a minority assert that official channels are downplaying an unknown pathogen. These claims are not substantiated by high-credibility sources, though the absence of comprehensive national reporting in the US complicates independent verification. The primary official message remains consistent: H3N2 is dominant, and while VE may be reduced due to drift, vaccination still confers benefit[^1][^2][^4][^10][^15][^16][^17].

Key indicators to monitor over the next 7–30 days include: (1) any rapid shifts in the proportion of H3 subclade K across US surveillance regions; (2) ED capacity trajectories in reported hotspot cities; (3) the resumption and completeness of national US respiratory dashboards; (4) credible whistleblower signals from hospitals; and (5) any credible evidence of novel or significantly mismatched pathogens. At this time, there is no verified evidence of a novel pathogen driving global surges. The most plausible near-term risk scenario is a severe H3N2 season with reduced VE in adults, combined with localized hospital overload and persistent data blind spots[^1][^2][^10][^11][^12][^16].



## Objectives, Scope, and Methodology

This assessment is designed to support strategic decision-making for public health analysts, OSINT investigators, policy makers, healthcare operations leaders, and risk assessment teams. The objectives are to: (1) triangulate social, news, and official signals of respiratory illness; (2) identify contradictions to official narratives; (3) assess surveillance capacity, disruptions, and blind spots; and (4) differentiate credible early signals from background noise.

The scope spans the United States, Canada, the United Kingdom, Japan, China, and Australia, with emphasis on known H3N2 hotspots and capacity-challenged EDs. Methods included systematic keyword scanning on social platforms; targeted review of credible media and official portals; and cross-referencing of social narratives with published evidence on information dynamics, to prevent over-weighting unverified claims[^15].

Credibility tiers were applied as follows: Tier 1 (official agencies and peer-reviewed literature), Tier 2 (major news organizations and recognized expert journalists), and Tier 3 (social media and alternative media). Data limitations include the US surveillance blackout, variable transparency in subnational reporting, and the inherent noise in social signals. Key exclusions include absence of verified leaks or whistleblowers specific to the current season, and limited availability of geocoded citizen reports outside the highlighted hotspots[^10][^11][^12].



## Current Global Respiratory Illness Landscape (Official Signals)

Global signals point to an H3N2-dominant season with early surges in multiple countries. Official and expert reporting indicate that the United Kingdom and Japan experienced very early starts driven by subclade K, while US activity is currently described as low overall at the national level, though this assessment is caveated by the absence of routine national surveillance updates since late September[^1][^2][^4][^10]. In China, authorities report heightened monitoring for emerging respiratory diseases, with human metapneumovirus (hMPV) trends noted among children in northern provinces and broader seasonal increases expected in winter and spring[^16]. The United States Centers for Disease Control and Prevention (CDC) continues to classify national acute respiratory illness levels as low as of early December, but this snapshot must be interpreted in the context of significant reporting disruptions[^10].

To illustrate the contrast across geographies and sources, Table 1 summarizes dominant narratives and official status.

Table 1. Global snapshot of activity and narratives (as of 2025-12-06 baseline)

| Region        | Dominant Strain/Pathogen     | Activity Trend          | Official Surveillance Status                                 | Key References |
|---------------|-------------------------------|-------------------------|---------------------------------------------------------------|----------------|
| United States | Influenza A(H3N2)             | National level “low”    | Routine national dashboards paused since Sept 26; state-level heterogeneity | [^1][^2][^10] |
| Canada        | Influenza rising; COVID mixed | Early seasonal rise     | Provincial tools active;局部 strain data limited             | [^7][^18]     |
| United Kingdom| H3N2 (subclade K dominant)    | Early, steep surge      | UKHSA publishes interim VE and strain characterization        | [^2][^5]      |
| Japan         | H3N2 (subclade K)             | Early surge             | Expert commentary; media corroboration                        | [^1][^4]      |
| China         | hMPV; influenza; rhinovirus    | Upward trend in under-14| China pilots pneumonia-of-unknown-origin monitoring           | [^16]         |
| Australia     | Mixed respiratory viruses     | Seasonal onset; ED stress| Hospital capacity signals prominent (Adelaide)               | [^8][^9]      |

This global mosaic suggests a classic H3N2 season with early ignition in temperate northern hemisphere settings and capacity stressors in specific hospital systems. The US situation is particularly difficult to interpret due to the suspension of national reporting, underscoring the importance of triangulating alternative data sources[^1][^10][^11][^12].

### United States

Multiple sources converge on the expectation that H3N2 will predominate, with potential VE mismatch concerns for adults. While the national respiratory illness data channel reports low levels, this coexists with local media reporting early spikes in certain counties and national coverage of the H3N2 “subclade K” variant narrative. Expert commentary emphasizes that H3N2-dominant seasons often present lower VE and more severe illness in older adults, but vaccination remains recommended[^1][^2][^3][^4][^10].

The table below links US national signals with local media perspectives.

Table 2. US national vs local signals

| Signal Type | Observation | Interpretation | References |
|-------------|-------------|----------------|------------|
| National dashboard | Acute respiratory illness at “low” level as of early Dec | Consistency with off-season baselines, but limited by data pause | [^10] |
| National narrative | H3N2 dominance expected; subclade K present | Supports global pattern; watch for mismatch implications | [^1][^2][^4] |
| Local media       | Early county-level flu spikes; concerns about variant | Indicates local accelerations; national blind spot complicates context | [^3] |

In sum, US signals are mixed: the official national posture is cautious, while local narratives and global comparators warrant heightened vigilance for rapid in-season changes[^1][^2][^3][^4][^10].

### Canada

Provincial surveillance tools remain active and show an earlier-than-usual rise in respiratory activity, with northern Ontario hospitals already reporting ED overcrowding driven by influenza and COVID-19 co-circulation. Local clinicians describe compounded effects on throughput and wait times, consistent with seasonal surge planning scenarios[^7][^18]. While aggregate national strain distributions are less granular in the public domain, provincial dashboards help fill part of the visibility gap.

### United Kingdom and Japan

Expert reporting indicates that the UK and Japan experienced very early starts to their flu seasons, driven by H3N2 subclade K. UK interim VE analyses suggest moderate protection in adults and higher protection in children, though these are early-season estimates and subject to refinement as the season progresses[^2][^5]. Regional surges in these countries often foreshadow patterns in neighboring systems and are relevant to US-Canada cross-border planning.

### China

China’s disease control authority is piloting a monitoring system for pneumonia of unknown origin, explicitly building capacity to detect and manage novel pathogens. Recent weeks show upward trends in acute respiratory diseases, with hMPV notable among children under 14 in northern provinces. Authorities advise against blind antiviral use for hMPV, for which no vaccine exists. Historically, similar winter surges in China have been linked to known pathogens such as influenza, RSV, adenovirus, and hMPV, rather than novel agents[^16].

### Australia

Australia’s season is in transition, with ED signals凸显系统压力. Reports from South Australia describe extreme overcrowding at the Royal Adelaide Hospital (RAH), including claims that admitted inpatients exceeded the ED’s 68 treatment spaces, prompting emergency demand escalation measures. Clinicians warn of “hidden ramping” and prolonged ED stays, highlighting patient safety risks and system-wide bottlenecks, notably in aged care placement[^8][^9].



## Social Media Intelligence (Twitter/X): Patterns and Citizen Reports

Across social platforms, the dominant discourse is broadly consistent with official messaging: H3N2 is the main driver of influenza activity, with emphasis on vaccination, ventilation, and mask use in crowded indoor settings. Clinicians and public health commentators reinforce standard mitigation measures and air safety practices. Citizen narratives frequently describe prolonged coughs, pneumonia, and multi-week recovery patterns, but these accounts generally align with seasonal flu presentations and do not point to a distinct, unknown syndrome. A minority of posts allege misclassification of SARS-CoV-2 as influenza, or longer-term health impacts from repeated infections, but these claims remain unverified by high-credibility sources in this dataset[^1][^15].

To anchor the social signal landscape, Table 3 distills representative themes.

Table 3. Social signal index (illustrative)

| Theme | Representative Signal | Sentiment | Geographic Tag | Notes |
|-------|------------------------|-----------|----------------|-------|
| H3N2 dominance | “H3N2 makes up the lion’s share of flu viruses this season” | Concerned | UK/US | Aligns with expert narratives on subclade K dominance[^2][^4] |
| ED overcrowding | Adelaide EDs critically overcrowded (>125% capacity) | Alarm | Adelaide | Consistent with institutional statements[^6] |
| Clinician mitigation | “Wear respirators in shared air spaces; clean indoor air” | Proactive | Global/US | Reinforces standard infection control advice[^1] |
| Citizen illness narratives | Prolonged cough; “walking pneumonia”; multi-week recovery | Mixed | US | Typically consistent with known pathogens; no novel pattern |
| Contradictory claims | “COVID is being misdiagnosed as flu” | Skeptical | US | Not substantiated by official sources in this dataset[^10][^15] |

Overall, social discourse is richest on mitigation and local capacity stressors. The dominant H3N2 storyline is well represented, though the vaccine mismatch discussion varies in technical accuracy, highlighting the need for clear public communication[^1][^2][^4][^15].



## Hospital Capacity and ER Overload: Cross-Jurisdiction Signals

Adelaide is the clearest capacity outlier. Emergency clinicians reported that RAH’s ED reached a tipping point in September 2025, with all 68 treatment spaces occupied by admitted inpatients and no space for new arrivals. The facility reportedly initiated a demand escalation framework. SA Health disputed the precise headcount but acknowledged the ED was well above optimal limits. The broader driver is system-wide bed block, with hundreds of patients awaiting aged care placement, delaying discharges and prolonging ED boarding[^8][^9].

In Northern Ontario, clinicians describe an earlier-than-usual rise in influenza and COVID-19, atop a persistently high baseline of emergency demand. Overcrowding slows care, lengthens waits, and complicates staffing logistics. This dynamic mirrors classic seasonal surge planning challenges but arrives early in the season, potentially compressing the time window for operational adaptation[^7].

Table 4. ED overcrowding summary (selected jurisdictions)

| Location | Date/Period | Capacity Indicator | Drivers | Sources |
|----------|-------------|--------------------|---------|---------|
| Adelaide (RAH) | Sep 22, 2025 (reported Nov 2025) | 70 admitted inpatients in a 68-space ED; all spaces occupied | Bed block; aged care placement delays; “hidden ramping” | [^8][^9] |
| Northern Ontario | Nov 2025 | Early seasonal surge atop chronic overcrowding | Influenza and COVID co-circulation; staffing and throughput pressures | [^7] |

These snapshots triangulate with prior seasonal experience: when EDs routinely board admitted patients for many hours, adverse outcomes rise, and hospital-wide efficiency degrades. Prolonged stays beyond eight hours are associated with increased risk, and clinicians caution that no patient should remain in the ED for more than 12 hours[^8].



## Contradictions, Discrepancies, and “Unusual” Narratives

The dominant official narrative—an H3N2-driven season with early surges in parts of the Northern Hemisphere—aligns closely with credible expert and media reporting. The key controversy this season is not the presence of a novel pathogen, but the intersection of a drifted H3N2 variant (subclade K) with uncertain VE and a US surveillance blackout that limits real-time verification. Social media claims that SARS-CoV-2 is being misdiagnosed as influenza, or that a “mysterious” illness is being hidden, are not substantiated by high-credibility sources. Nonetheless, the absence of routine national dashboards in the US amplifies uncertainty and can fuel speculation[^1][^2][^4][^10][^11][^12][^15][^17].

Table 5. Contradiction matrix (selected claims)

| Claim | Official/Evidence | Likely Verdict | Sources |
|-------|--------------------|----------------|---------|
| A novel pathogen is driving global surges | China reports known pathogens (influenza, hMPV, rhinovirus); pilots monitoring for unknown causes | Not supported | [^16] |
| SARS-CoV-2 cases are being misclassified as flu | National US surveillance paused; no corroboration from credible sources in this dataset | Unsubstantiated; monitoring warranted | [^10][^11][^12][^15] |
| H3N2 vaccine is badly mismatched this season | Subclade K drift recognized; interim VE suggests moderate protection in adults, higher in children; situation evolving | Partially supported; mismatch risk noted | [^1][^2][^5] |
| Hospitals are hiding true etiologies | No credible evidence of systematic concealment in current season; capacity stressors are documented | Not supported | [^6][^8][^9] |

The core discrepancy is therefore epistemic: reduced transparency in national data (US) intersects with a season characterized by drift and early surges, producing fertile ground for divergent narratives. In this environment, triangulation and cautious communication are essential[^10][^11][^12][^15].



## Underground and Alternative Channels: Leaks, Whistles, and Suppressed Information

No verified leaks, whistleblower documents, or suppressed official datasets specific to the current season were identified in the collected sources. This stands in contrast to historical episodes (e.g., early COVID-19 and SARS) where whistleblowers and internal documents shaped the information environment. The present analysis therefore leans on official channels and credible media, with social media used as a signal amplifier rather than a primary evidence base.

The absence of underground corroboration in this dataset should not be construed as evidence of uniform transparency. It does, however, underscore the importance of resumed national surveillance in the US to reduce information asymmetries that otherwise invite speculation[^10][^11].



## Cross-Reference Analysis: Social vs Official vs News

Triangulation suggests strong alignment among official and expert narratives in jurisdictions with functioning surveillance. Where divergence emerges, it is driven by the US surveillance gap and local capacity realities rather than by confirmed contradictions about etiology. Hospital EDs under strain report what clinicians see: an earlier surge layered on chronic overcrowding. In the UK and Japan, early H3N2 surges were observed with clear public messaging and analytic outputs (e.g., interim VE). In the US, the absence of regular national updates constrains the ability to corroborate local spikes or to contextualize them nationally[^1][^2][^6][^7][^10][^15].

Table 6. Cross-reference matrix (selected signals)

| Topic | Social Signal | Official Signal | News/Media | Convergence Score (1–5) | Notes |
|-------|---------------|-----------------|------------|--------------------------|-------|
| H3N2 dominance | Frequent mentions; concern about severity | H3N2 expected to predominate; subclade K present | Broad coverage of variant | 5 | Strong consensus across sources[^1][^2][^4] |
| Vaccine mismatch | Worries about poor protection | Drift noted; VE uncertain/moderate | Reports of potential mismatch | 4 | Early-season estimates; watch week-to-week[^1][^2][^5] |
| ED overcrowding | Adelaide >125%; Ontario lines | Institutional admissions above optimal | Local coverage of pressure | 5 | Clear, consistent cross-source signals[^6][^7][^8][^9] |
| National US visibility | Calls for more data | Dashboards paused since Sept 26 | Coverage of blackout | 5 | Consensus on disruption[^10][^11][^12] |
| Misclassification claims | Some allegations | No corroboration | Rare, cautious | 2 | Insufficient evidence; monitor[^10][^15] |

The analysis supports a high-confidence conclusion that the season’s dynamics are driven by H3N2, with material uncertainty introduced by VE mismatch and US data blackouts. Capacity risks are concentrated in specific locales with pre-existing bottlenecks.



## Threat Assessment and Strategic Implications

Epidemiological risk. An H3N2-predominant season with drift (subclade K) typically portends heavier clinical burden, especially among older adults, and reduced VE versus other subtypes. Early-season indicators in the UK and Japan, combined with US news coverage, elevate the risk of a severe season in North America if the mismatch persists and mitigation is insufficient[^1][^2][^4][^5].

Operational risk. The convergence of a potentially severe influenza season with ED overcrowding in Adelaide and early surges in Northern Ontario increases the probability of delayed care, increased adverse events, and staff burnout. Absent national dashboards in the US, hospitals and public health agencies face added planning uncertainty[^6][^7][^8][^9][^10][^11][^12].

Information risk. The US surveillance blackout impairs situational awareness and may erode trust if not mitigated with clear communication and restored reporting. Social narratives—some accurate, some speculative—will fill vacuums. Evidence shows official messages are generally more effective at guiding public knowledge, but their absence or infrequency allows contradictory narratives to gain traction[^10][^11][^12][^15].

Strategic implications. Priority actions include restoring national reporting streams in the US; augmenting subnational data sharing; targeted risk communication on VE and mitigation; and hospital capacity surge planning for known hotspots. International coordination should focus on shared definitions, compatible dashboards, and rapid publication of VE and strain characterization to guide mid-season course corrections[^1][^2][^5][^10][^11][^12].



## Actionable Recommendations (7–30 Days)

1) Monitoring. Establish a daily watch on: (a) US national respiratory dashboards for resumption and completeness; (b) state/provincial updates in high-risk regions; (c) Adelaide and Northern Ontario ED capacity indicators; (d) UKHSA interim VE updates; and (e) credible clinician and hospital official channels on Twitter/X for early alerts[^5][^6][^7][^10][^18].

2) Verification. Where social claims intersect with operations (e.g., ED overload), corroborate through official hospital statements and regional health authorities. Escalate only those claims that pass triangulation across at least two credible tiers (Tier 1–2).

3) Communication. Develop and disseminate clear messaging: (a) vaccination remains recommended despite mismatch risk; (b) targeted non-pharmaceutical interventions (masking in crowded indoor settings; ventilation; staying home when ill); and (c) transparency about data limitations and expected update schedules[^1][^2][^10][^15][^17].

4) Data augmentation. Encourage and, where possible, support restoration of wastewater surveillance, RESP-NET, and FluView-like reporting streams; create lightweight local dashboards in collaboration with hospital partners to track ED throughput and admissions for respiratory syndromes[^10][^11][^12].

5) Clinical readiness. Review antiviral stewardship, triage protocols, and bed management in EDs anticipating prolonged lengths of stay. Coordinate with aged care and post-acute care providers to reduce boarding delays in high-risk hospitals[^8][^9].



## Appendices

### Appendix A: Search Term Catalog and Coverage Notes

Table A1. Search terms by objective and typical source type

| Objective | Example Search Terms | Typical Source Types |
|-----------|----------------------|---------------------|
| Outbreak detection | “respiratory illness outbreak”; “unusual flu”; “mysterious illness” | Official dashboards; major media; public health accounts |
| Hospital capacity | “hospital capacity”; “ER overload”; “ED boarding” | Hospital statements; clinician accounts; local media |
| Etiology and mismatch | “H3N2 subclade K”; “vaccine mismatch” | Expert analysis; scientific/preprint; health agencies |
| Information suppression | “surveillance blackout”; “CDC data pause” | National media; policy analysis |
| Underground signals | “whistleblower”; “leaked” | Historical context; no current-season corroborated signals |

Coverage notes: US national surveillance pause constrained confirmation of national trends. Adelaide and Northern Ontario capacity signals were among the most consistently corroborated across institutional and media sources[^10][^11][^12][^6][^7][^8][^9].

### Appendix B: Source Reliability Rubric

Table B1. Reliability tiers and usage guidance

| Tier | Source Type | Examples | Guidance |
|------|-------------|----------|----------|
| 1 | Official agencies; peer-reviewed literature | CDC, WHO, UKHSA interim VE, peer-reviewed studies | Use as anchors for conclusions and policy |
| 2 | Major media; recognized experts | CBC, ABC, CNN, CIDRAP, established science journalists | Use to contextualize and provide regional detail |
| 3 | Social and alternative media | Twitter/X, Facebook posts, blogs | Use for signal detection; verify before escalation |

Application: This rubric was applied throughout the cross-reference analysis. Where Tier 3 signals were the only source (e.g., unverified social claims), they were treated as hypotheses, not evidence[^10][^15].

### Appendix C: Glossary

- H3N2: Influenza A subtype, often associated with more severe seasons and lower vaccine effectiveness.
- Subclade K: A genetically distinct grouping within H3N2 referenced in recent UK and Japanese reports; associated with early surges and potential mismatch.
- VE (Vaccine effectiveness): The proportionate reduction in disease among vaccinated individuals compared to unvaccinated; season- and subtype-dependent.
- RESP-Net: A hospital-based surveillance network tracking respiratory disease hospitalizations for COVID-19, influenza, and RSV.
- hMPV (Human metapneumovirus): A respiratory virus that can cause upper and lower respiratory tract disease; no widely available vaccine.



## Information Gaps

- No verified whistleblower documents or leaked medical records specific to the current season were identified.
- Limited availability of current-week US national surveillance data due to the shutdown-related pause.
- Sparse geocoded social signals for city-level clusters outside highlighted hotspots (Adelaide, Northern Ontario).
- Incomplete real-time strain typing by region, especially in US subnational jurisdictions.
- Absence of reliable access to some paywalled local reporting; reliance on publicly accessible summaries.
- No confirmed evidence of information suppression beyond the known national reporting blackout; attribution remains uncertain.



## References

[^1]: CIDRAP. With an absent CDC and mismatched 'subclade K' flu strain, experts face upcoming season with uncertainty. https://www.cidrap.umn.edu/influenza-vaccines/absent-cdc-and-mismatched-subclade-k-flu-strain-experts-face-upcoming-season

[^2]: UK Health Security Agency. Interim effectiveness estimates of 2025–26 influenza vaccines (PDF). https://assets.publishing.service.gov.uk/media/691349457a0ccd6a3aad7fa9/_Flu_interimVE_2526_.pdf

[^3]: Democrat and Chronicle. Monroe County flu cases spike early — what to know about H3N2 variant. https://www.democratandchronicle.com/story/news/health/2025/12/04/what-to-know-about-h3n2-flu-variant/87554335007/

[^4]: NBC News. Warnings rise for U.S. as severe flu strain H3N2 causes outbreaks in Canada and U.K. https://www.nbcnews.com/health/health-news/evere-flu-strain-h3n2-us-response-outbreaks-canada-uk-rcna243431

[^5]: UK Health Security Agency. Interim effectiveness estimates of 2025–26 influenza vaccines (PDF). https://assets.publishing.service.gov.uk/media/691349457a0ccd6a3aad7fa9/_Flu_interimVE_2526_.pdf

[^6]: Adelaide Emergency Departments (Twitter/X). EDs critically overcrowded. https://twitter.com/AdlEmergStatus/status/1996829397198970885

[^7]: CBC. Hospital overcrowding makes flu response in northern Ontario more challenging. https://www.cbc.ca/news/canada/sudbury/flu-season-covid-vaccination-9.6986640

[^8]: ABC News (Australia). ED doctors under pressure at Royal Adelaide Hospital. https://www.abc.net.au/news/2025-11-01/ed-doctors-under-pressure-at-royal-adelaide-hospital/105952042

[^9]: Australasian College for Emergency Medicine (ACEM). ‘Hidden ramping’ straining South Australia’s emergency departments. https://acem.org.au/News/November-2025/%E2%80%98Hidden-ramping%E2%80%99-straining-South-Australia%E2%80%99s-emerg

[^10]: CDC. Respiratory Illnesses Data Channel. https://www.cdc.gov/respiratory-viruses/data/index.html

[^11]: CNN. As respiratory virus season begins, federal shutdown leaves critical gap in surveillance. https://www.cnn.com/2025/10/22/health/disease-surveillance-government-shutdown

[^12]: Governing. Government Shutdown Leaves States Unarmed in Tracking Disease. https://www.governing.com/management-and-administration/government-shutdown-leaves-states-unarmed-in-tracking-disease

[^13]: CIDRAP. Pneumonia outbreak in Chinese kids linked to known pathogens. https://www.cidrap.umn.edu/adenovirus/pneumonia-outbreak-chinese-kids-linked-known-pathogens

[^14]: University of Nebraska Medical Center (UNMC). Mystery child pneumonia outbreak reported in China hospitals. https://www.unmc.edu/healthsecurity/transmission/2023/11/22/mystery-child-pneumonia-outbreak-reported-in-china-hospitals/

[^15]: Journal of Medical Internet Research (JMIR). Understanding the Relationship Between Official and Social Information About Infectious Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC8663576/

[^16]: Reuters. China steps up monitoring of emerging respiratory diseases. https://www.reuters.com/world/china/china-steps-up-monitoring-emerging-respiratory-diseases-2024-12-27/

[^17]: CDC. Other Respiratory Illnesses Going Around. https://www.cdc.gov/respiratory-viruses/data/illnesses-going-around.html

[^18]: Public Health Ontario. Ontario Respiratory Virus Tool. https://www.publichealthontario.ca/en/About/News/2025/10/October-2025-Enhancements-ORVT

[^19]: 8 News Now. Cases of ‘walking pneumonia’ are rising across the US: Where is it worst? https://www.8newsnow.com/news/national-news/cases-of-walking-pneumonia-are-rising-across-the-us-heres-where-its-worst/

[^20]: Forbes. Mycoplasma likely main culprit of outbreak of pediatric cases of pneumonia worldwide. https://www.forbes.com/sites/joshuacohen/2023/11/25/mycoplasma-likely-main-culprit-of-outbreak-of-pediatric-cases-of-pneumonia-worldwide/